AAAAAA
Results:
1-8
|
Results: 8
Authors:
Clive, DLJ
Yang, HK
Lewanczuk, RZ
Citation: Dlj. Clive et al., Synthesis and in vitro activity of a non-epimerizable analog of the angiotensin-converting enzyme inhibitor A58365A, CR AC S IIC, 4(6), 2001, pp. 505-512
Authors:
Ginsberg, J
Lewanczuk, RZ
Honore, LH
Citation: J. Ginsberg et al., Hyperplacentosis: A novel cause of hyperthyroidism, THYROID, 11(4), 2001, pp. 393-396
Authors:
Romney, JS
Lewanczuk, RZ
Citation: Js. Romney et Rz. Lewanczuk, Vascular compliance is reduced in the early stages of type 1 diabetes, DIABET CARE, 24(12), 2001, pp. 2102-2106
Authors:
Krylova, SM
Pang, PKT
Shan, J
Lewanczuk, RZ
Benishin, CG
Citation: Sm. Krylova et al., Quantitative determination of parathyroid hypertensive factor by enzyme-linked immunosorbent assay, AM J HYPERT, 13(11), 2000, pp. 1173-1179
Authors:
Mostafavi, SA
Lewanczuk, RZ
Foster, RT
Citation: Sa. Mostafavi et al., Influence of acebutolol and metoprolol on cardiac output and regional blood flow in rats, BIOPHARM DR, 21(4), 2000, pp. 121-128
Authors:
Cheung, R
Lewanczuk, RZ
Rodger, NW
Huff, MW
Oddou-Stock, P
Botteri, F
Pecher, E
Muirhead, N
Citation: R. Cheung et al., The effect of valsartan and captopril on lipid parameters in patients withtype II diabetes mellitus and nephropathy, INT J CL PR, 53(8), 1999, pp. 584
Authors:
Benishin, CG
Lewanczuk, RZ
Shan, JJ
Pang, PKT
Citation: Cg. Benishin et al., Parathyroid hypertensive factor secretion from subcultured spontaneously hypertensive rat parathyroid cells, AM J HYPERT, 12(12), 1999, pp. 1260-1263
Authors:
Muirhead, N
Feagan, BF
Mahon, J
Lewanczuk, RZ
Rodger, NW
Botteri, F
Oddou-Stock, P
Pecher, E
Cheung, R
Citation: N. Muirhead et al., The effects of valsartan and captopril on reducing microalbuminuria in patients with type 2 diabetes mellitus: A placebo-controlled trial, CURR THER R, 60(12), 1999, pp. 650-660
Risultati:
1-8
|